Minimal model: perspective from 2005 - PubMed (original) (raw)
Review
doi: 10.1159/000089312. Epub 2006 Jan 20.
Affiliations
- PMID: 16439839
- DOI: 10.1159/000089312
Review
Minimal model: perspective from 2005
Richard N Bergman. Horm Res. 2005.
Abstract
The minimal model was proposed over 25 years ago. Despite (or because of) its simplicity it continues to be used today - both as a clinical tool and an approach to understanding the composite effects of insulin secretion and insulin sensitivity on glucose tolerance and risk for type 2 diabetes mellitus. The original assumptions of the model have led to an understanding of the kinetics of insulin in vivo, as well as the relative importance of beta-cell compensatory failure in the pathogenesis of diabetes. The disposition index (DI), a parameter emerging from the model, represents the ability of the pancreatic islets to compensate for insulin resistance. There is evidence that a locus on chromosome 11 codes for the DI, which has a significant heritability and can predict type 2 diabetes better than any known genetic locus. Even today, the model continues to be a subject of scientific discovery and discourse.
Copyright (c) 2005 S. Karger AG, Basel.
Similar articles
- Beta-cell function and mass in type 2 diabetes.
Larsen MO. Larsen MO. Dan Med Bull. 2009 Aug;56(3):153-64. Dan Med Bull. 2009. PMID: 19728971 - Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
Calderari S, Gangnerau MN, Meile MJ, Portha B, Serradas P. Calderari S, et al. Pancreas. 2006 Nov;33(4):412-7. doi: 10.1097/01.mpa.0000236739.69735.20. Pancreas. 2006. PMID: 17079948 - Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
Bardini G, Dicembrini I, Pala L, Cresci B, Rotella CM. Bardini G, et al. Diabet Med. 2011 Oct;28(10):1229-33. doi: 10.1111/j.1464-5491.2011.03332.x. Diabet Med. 2011. PMID: 21923697 - Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Gastaldelli A. Gastaldelli A. Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S60-5. doi: 10.1016/S0168-8227(11)70015-8. Diabetes Res Clin Pract. 2011. PMID: 21864753 Review. - The GK rat: a prototype for the study of non-overweight type 2 diabetes.
Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H, Movassat J. Portha B, et al. Methods Mol Biol. 2012;933:125-59. doi: 10.1007/978-1-62703-068-7_9. Methods Mol Biol. 2012. PMID: 22893405 Review.
Cited by
- Beta cell dysfunction and insulin resistance.
Cerf ME. Cerf ME. Front Endocrinol (Lausanne). 2013 Mar 27;4:37. doi: 10.3389/fendo.2013.00037. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 23542897 Free PMC article. - Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists.
Ramasubbu MK, Paleja B, Srinivasann A, Maiti R, Kumar R. Ramasubbu MK, et al. Indian J Pharmacol. 2024 Jul 1;56(4):268-276. doi: 10.4103/ijp.ijp_644_23. Epub 2024 Sep 10. Indian J Pharmacol. 2024. PMID: 39250624 Free PMC article. Review. - Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.
Shuster DL, Shireman LM, Ma X, Shen DD, Flood Nichols SK, Ahmed MS, Clark S, Caritis S, Venkataramanan R, Haas DM, Quinney SK, Haneline LS, Tita AT, Manuck TA, Thummel KE, Brown LM, Ren Z, Brown Z, Easterling TR, Hebert MF. Shuster DL, et al. Clin Pharmacol Ther. 2020 Jun;107(6):1362-1372. doi: 10.1002/cpt.1749. Epub 2020 Jan 25. Clin Pharmacol Ther. 2020. PMID: 31869430 Free PMC article. Clinical Trial. - Tissue-Specific and Genetic Regulation of Insulin Sensitivity-Associated Transcripts in African Americans.
Sharma NK, Sajuthi SP, Chou JW, Calles-Escandon J, Demons J, Rogers S, Ma L, Palmer ND, McWilliams DR, Beal J, Comeau ME, Cherry K, Hawkins GA, Menon L, Kouba E, Davis D, Burris M, Byerly SJ, Easter L, Bowden DW, Freedman BI, Langefeld CD, Das SK. Sharma NK, et al. J Clin Endocrinol Metab. 2016 Apr;101(4):1455-68. doi: 10.1210/jc.2015-3336. Epub 2016 Jan 20. J Clin Endocrinol Metab. 2016. PMID: 26789776 Free PMC article. - Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways.
Karandrea S, Yin H, Liang X, Slitt AL, Heart EA. Karandrea S, et al. PLoS One. 2017 Sep 26;12(9):e0185374. doi: 10.1371/journal.pone.0185374. eCollection 2017. PLoS One. 2017. PMID: 28950020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical